Medication info
Pencra Tablet 625 mg (Amoxicillin-Clavulanate Potassium (4:1))

Pencra Tablet 625 mg (Amoxicillin-Clavulanate Potassium (4:1))

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›500mg / 1 tabletDilute Potassium Clavulanate›215.52mg / 1 tablet
Manufacturer / importer
Penmix Co., Ltd.
Appearance
(For Sale) White or almost white rectangular film-coated tablets, (For Export) White or almost white oval film-coated tablets
Packaging
60 tablets/PTP (4 tablets x 15), (For Export) 40 tablets/PTP (4 tablets x 10)
Approval status
Active

MFDS item code 200303360 · Notified 2003.06.27 · Insurance code 677100260

Summary

Main use
Treatment of respiratory and otorhinolaryngologic infections, genitourinary infections, and skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
Adults: Administer amoxicillin/potassium clavulanate 250 mg/125 mg orally 3 times daily, every 8 hours; for severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. ○ In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. - Adults: 10 ~ 30 mL/min Administer 250 ~ 500 mg of amoxicillin orally per dose every 12 hours. 10 mL/min or less Administer 250 mg of amoxicillin per dose every 24 hours, without exceeding the dose. ○ However, for dental infections, administer 250 mg of amoxicillin per dose, 3 times daily for 5 days.
Child dose
Children aged 12 years and older or weighing 40 kg or more: Administer amoxicillin/potassium clavulanate 250 mg/125 mg orally 3 times daily, every 8 hours; for severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. Children: Reduce the dose using the same method.

Ingredients

Manufacturer
Penmix Co., Ltd.

Efficacy & effects

Treatment of respiratory and otorhinolaryngologic infections, genitourinary infections, and skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infection
View approved original text

This medication is used for respiratory infections such as acute and chronic bronchitis, pneumonia, tonsillitis, sinusitis, and otitis media. It is effective for the treatment of urinary infections including cystitis, urethritis, and pyelonephritis. It is also applicable for the treatment of gonorrhea and pelvic infections. It is used for skin and soft tissue infections such as boils, abscesses, cellulitis, and wound infections. Additionally, it helps in the treatment of osteomyelitis and dental infections. It is effective against various bacteria and used for the treatment of multiple infectious diseases.

How to take

Adult dose

Adults: Administer amoxicillin/potassium clavulanate 250 mg/125 mg orally 3 times daily, every 8 hours; for severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. ○ In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. - Adults: 10 ~ 30 mL/min Administer 250 ~ 500 mg of amoxicillin orally per dose every 12 hours. 10 mL/min or less Administer 250 mg of amoxicillin per dose every 24 hours, without exceeding the dose. ○ However, for dental infections, administer 250 mg of amoxicillin per dose, 3 times daily for 5 days.

Child dose

Children aged 12 years and older or weighing 40 kg or more: Administer amoxicillin/potassium clavulanate 250 mg/125 mg orally 3 times daily, every 8 hours; for severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. Children: Reduce the dose using the same method.

Precautions

This medication is a beta-lactam antibiotic and should not be administered to patients allergic to penicillin or cephalosporins. Patients with infectious mononucleosis or lymphocytic leukemia should be cautious when using this medication as the risk of rash may increase. Patients with a history of liver function issues should be careful, as symptoms may reappear after using this medication. Patients with impaired liver function or severe renal disease may experience increased drug concentration, necessitating dosage adjustments or modifications in medication intervals. Patients with allergies or gastrointestinal issues such as vomiting and diarrhea may not effectively absorb the medication, so caution is needed. This medication may cause diarrhea, gastritis, and vomiting in the gastrointestinal system, and in severe cases, serious side effects such as pseudomembranous colitis may occur. Elevated liver enzymes, hepatitis, jaundice, and other liver-related abnormalities may manifest, particularly reported more frequently among the elderly and males. Rarely, allergic reactions such as skin rash, itching, severe skin conditions, or anaphylaxis may occur, and if unusual symptoms arise, medication should be stopped immediately. Blood disorders may occur, including leukopenia, thrombocytopenia, and anemia; hence, blood tests are necessary for prolonged use. Neurological issues such as anxiety, drowsiness, or seizures may occur rarely, and patients with impaired kidney function may experience severe kidney problems such as acute renal failure. This medication can disrupt the intestinal bacterial balance, causing conditions like candidiasis or stomatitis. Long-term use may lead to vitamin K deficiency that increases bleeding risks; thus, the elderly or patients at risk of vitamin deficiency should be cautious. This medication may interact with other drugs, particularly anticoagulants, anti-inflammatory drugs, and oral contraceptives; consulting a physician or pharmacist is advised when used together. Pregnant women, especially in early pregnancy, may face risks when using this medication, and it should only be used when necessary. While breastfeeding, monitoring for adverse effects on the baby is advised. Not recommended for children under 12 years of age or those weighing less than 40 kg. Elderly patients may have decreased body functions, which could lead to side effects appearing more easily; therefore, careful adjustment of dosage and intervals is needed. During this medication, some clinical tests, such as urine sugar tests, may yield affected results, so this should be noted during testing. In case of overdose, symptoms like vomiting, diarrhea, renal failure, and seizures may occur, necessitating immediate medical attention for appropriate treatment.

Side effects

  • Diarrhea
  • pseudomembranous colitis
  • dyspepsia
  • stomatitis
  • gastritis
  • glossitis
  • black hairy tongue
  • nausea
  • vomiting
  • anorexia
Show 80 more
  • abdominal pain
  • abdominal distension
  • constipation
  • colonic pain
  • hyperacidity
  • soft stools
  • dry mouth
  • acute pancreatitis
  • candidiasis
  • antibiotic-induced colitis
  • hematochezia
  • itching
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • bullous pemphigoid
  • acute generalized pustular dermatosis
  • eosinophilia
  • angioedema
  • anaphylaxis
  • serum sickness syndrome
  • hypersensitivity vasculitis
  • bronchial spasm
  • dyspnea
  • laryngeal edema
  • anaphylactic shock
  • leukopenia
  • thrombocytopenia
  • hemolytic anemia
  • anemia
  • thrombocytopenic purpura
  • eosinophilia
  • leukemia
  • agranulocytosis
  • lymphopenia
  • thrombocytosis
  • bone marrow suppression
  • prolonged bleeding time
  • prolonged prothrombin time
  • vaginal itching
  • burning
  • increased secretion
  • restlessness
  • anxiety
  • changes in behavior
  • confusion
  • drowsiness
  • insomnia
  • hyperactivity
  • dizziness
  • headache
  • convulsions
  • antispasmodic
  • fever
  • altered consciousness
  • aseptic meningitis
  • acute renal failure
  • interstitial nephritis
  • hematuria
  • crystalluria
  • symptoms of vitamin K deficiency
  • hypoprothrombinemia
  • tendency to bleed
  • symptoms of vitamin B deficiency
  • linear IgA disease
  • taste disturbance
  • malaise
  • dermatitis
  • oral edema
  • gastric pain
  • fluid and electrolyte imbalance
  • rash
  • hyperactivity
  • drowsiness
  • symptoms of kidney failure
  • epileptic seizures
  • hypersensitivity shock
  • skin reactions
  • hemorrhage
  • pancytopenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is stored in a sealed container to prevent moisture. When storing, it should be kept in a place that is dry and has low humidity, ideally maintaining a temperature below 25 degrees Celsius. This way, the effectiveness of the medication can be maintained for a long time.

Appearance and packaging

Appearance

(For Sale) White or almost white rectangular film-coated tablets, (For Export) White or almost white oval film-coated tablets

Package unit

60 tablets/PTP (4 tablets x 15), (For Export) 40 tablets/PTP (4 tablets x 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.